AstraZeneca PLC (AZN)
159.20
+0.42
(+0.26%)
USD |
NYSE |
Oct 09, 16:00
160.00
+0.80
(+0.50%)
After-Hours: 20:00
AstraZeneca Free Cash Flow (Quarterly) : 1.885B for March 31, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 1.885B |
| December 31, 2025 | 1.121B |
| September 30, 2025 | 3.484B |
| June 30, 2025 | 1.561B |
| March 31, 2025 | 2.811B |
| December 31, 2024 | 2.014B |
| September 30, 2024 | 2.10B |
| June 30, 2024 | 2.53B |
| March 31, 2024 | 974.00M |
| December 31, 2023 | 1.513B |
| September 30, 2023 | 2.309B |
| June 30, 2023 | 1.302B |
| March 31, 2023 | 1.73B |
| December 31, 2022 | 1.878B |
| September 30, 2022 | 1.835B |
| June 30, 2022 | 712.00M |
| March 31, 2022 | 2.872B |
| December 31, 2021 | 706.00M |
| September 30, 2021 | 1.06B |
| June 30, 2021 | 542.00M |
| March 31, 2021 | 1.489B |
| December 31, 2020 | 1.254B |
| September 30, 2020 | 1.123B |
| June 30, 2020 | 72.00M |
| March 31, 2020 | -209.00M |
| Date | Value |
|---|---|
| December 31, 2019 | 1.007B |
| September 30, 2019 | 797.00M |
| June 30, 2019 | -60.00M |
| March 31, 2019 | -1.111B |
| December 31, 2018 | 1.857B |
| September 30, 2018 | 230.00M |
| June 30, 2018 | -206.00M |
| March 31, 2018 | -443.95M |
| December 31, 2017 | 492.00M |
| September 30, 2017 | 1.933B |
| June 30, 2017 | -51.00M |
| March 31, 2017 | -252.00M |
| December 31, 2016 | 1.354B |
| September 30, 2016 | 480.83M |
| June 30, 2016 | -791.26M |
| March 31, 2016 | 919.94M |
| December 31, 2015 | 57.00M |
| September 30, 2015 | 1.254B |
| June 30, 2015 | 455.00M |
| March 31, 2015 | -1.107B |
| December 31, 2014 | 1.417B |
| September 30, 2014 | 1.566B |
| June 30, 2014 | 971.81M |
| March 31, 2014 | 491.10M |
| December 31, 2013 | 1.724B |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| GSK Plc | 2.511B |
| Johnson & Johnson | 7.295B |
| Eli Lilly & Co. | 4.475B |
| Merck & Co., Inc. | 4.477B |
| Novo Nordisk A/S | 6.362B |